Tolerion, Inc.
Biotechnology ResearchCalifornia, United States11-50 Employees
Tolerion is a clinical-stage biopharmaceutical company with a product portfolio built around our novel antigen-specific immune tolerance induction platform.
Innovative Platform Tolerion specializes in a novel antigen-specific immune tolerance induction platform, which positions it as a leader in targeted immune therapies and presents opportunities for partnerships with pharmaceutical companies seeking innovative biotechnologies.
Early-Stage Revenue With a revenue range of zero to one million dollars, Tolerion is in an early commercial stage, offering potential for strategic collaborations and investments to accelerate product development and market entry.
Niche Focus Operating in the specialized field of biotech research with a focus on immune tolerance, Tolerion offers tailored solutions that could appeal to healthcare providers and biotech firms interested in cutting-edge autoimmune therapies.
Limited Workforce With a small team of 11 to 50 employees, Tolerion presents opportunities for scalable growth and capacity expansion through strategic partnerships and talent acquisition to support R&D and commercialization efforts.
Competitive Edge Positioned among similar early-stage biotech companies, Tolerion’s unique immune tolerance platform may attract interest from larger biotech and pharmaceutical organizations seeking to diversify their portfolios with innovative immune modulation therapies.
Tolerion, Inc. uses 8 technology products and services including WordPress, Font Awesome, Google Fonts API, and more. Explore Tolerion, Inc.'s tech stack below.
| Tolerion, Inc. Email Formats | Percentage |
| FLast@tolerion.bio | 30% |
| Last@tolerion.bio | 20% |
| FLast@tolerion.bio | 30% |
| Last@tolerion.bio | 20% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Tolerion is a clinical-stage biopharmaceutical company with a product portfolio built around our novel antigen-specific immune tolerance induction platform.
Tolerion, Inc.'s revenue is estimated to be in the range of $1M
Tolerion, Inc.'s revenue is estimated to be in the range of $1M